BIO is expected to report earnings to fall 19.29% to $2.51 per share on October 24
Q3'24
Est.
$2.51
Q2'24
Beat
by $1.10
Q1'24
Beat
by $0.14
Q4'23
Beat
by $0.28
Q3'23
Missed
by $0.45
The last earnings report on August 01 showed earnings per share of $3.11, beating the estimate of $2.01. With 141.66K shares outstanding, the current market capitalization sits at 9.79B.